[1]
Spresser, C.R. and Fleming, A. 2011. Central Diabetes Insipidus as a Manifestation of AML Secondary to Temodar Therapy for Pancreatic Neuroendocrine Tumor. Kansas Journal of Medicine. 4, S1 (Oct. 2011). DOI:https://doi.org/10.17161/kjm.v4i3.11359.